44 episodes
DCAT Value Chain Insights Podcast DCAT
-
- Business
The DCAT Value Chain Insights Podcast, presented by the Drug, Chemical & Associated Technologies Association, presents specially selected articles from our website (DCATvci.org) that feature in-depth analysis on the issues impacting the business of pharmaceutical development and manufacturing.
-
What’s Trending: Parenteral Drug Development & Manufacturing
What are some key trends and issues arising in parenteral drug development and manufacturing? From more complex molecules and modalities and sterile drug-product capacity market shifts, DCAT Value Chain Insights takes an inside look. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers in drop down menu in audio player above)
Major trends in parenteral drug development Long peptides in NDAs and BLAs New complex modalities Sterile drug-product capacity market shifts Complex sterile injectables Regulatory issues Digitalization and automation Podcast Sponsor: Vetter Pharma International GmbH
Links:
Subscribe to our e-newsletter at www.dcatvci.org
Follow us on Twitter @DCATvci
Support the show
Support the show -
CDMOs/CMOs: The Movers and Shakers of 2023
As 2023 comes to a close, what were the largest mergers and acquisitions and expansions made by CDMOs/CMOs in 2023? DCAT Value Chain Insights looks at which companies topped the headlines this year and the leading moves they made. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers in drop down menu in audio player above)
BaxterSamsung BiologicsLotte BiologicsFujifilm Diosynth BiotechnologiesLonza CambrexExpansions in peptides, oligonucleotides BachemAgilent TechnologiesWuXi STACordenPharmaAjinomotoBain’s acquisition of F.I.S.eureKINGNew CDMOs enter the market Bridgewest Group SynCrest NewBiologix Ascend Gene & Cell Therapies Podcast Sponsor: Vetter Pharma International GmbH
Links:
Subscribe to our e-newsletter at www.dcatvci.org
Follow us on Twitter @DCATvci
Support the show
Support the show -
CDMO/CMO Mid-Year Review: Tracking the Key Moves Thus Far in 2023
As we near the mid-year mark, what have been the key moves—mergers and acquisitions, expansions, and new CDMOs entering the market—thus far in 2023? DCAT Value Chain Insights takes an inside look on what is on the industry’s radar. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers in drop down menu in audio player above)
BaxterLarge-scale biomanufacturing expansions continue Samsung BiologicsLotte BiologicsFujifilm Diosynth BiotechnologiesLonza WuXi BiologicsExpansions in Peptides and Oligonucleotides Ramp UpBachemAgilent TechnologiesWuXi STACordenPharmaNew CDMOs Enter the Market eureKINGNewBiologixAscend Gene & Cell TherapiesPodcast Sponsor: Vetter Pharma International GmbH
Links:
Subscribe to our e-newsletter at www.dcatvci.org
Follow us on Twitter @DCATvci
Support the show
Support the show
Support the show -
API Alert: EU Proposes New Requirements To Secure Pharma Supply Chains
The European Commission has issued its long-awaited proposal to reform pharmaceutical legislation in the EU, the first major overhaul in 20 years, which includes new requirements to address drug shortages and secure supply chains. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers in drop down menu in audio player above)
Proposed reforms Security of supply and supply-chain reforms Specific proposals Podcast Sponsor: BIOVECTRA
Links:
Subscribe to our e-newsletter at www.dcatvci.org
Follow us on Twitter @DCATvci
Support the show
Support the show -
The CDMO/CMO Report: Parenteral Drugs
Increased demand in biologic-based drug development is a key factor driving demand for parenteral drug manufacturing. What are key trends and expansions by CDMO/CMOs in parenteral drug manufacturing? DCAT Value Chain Insights rounds up the latest developments among CDMO/CMOs. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers in drop down menu in audio player above)
Recent expansion projects Baxter BioPharma Solutions Vetter Recipharm WuXi STA Jubilant HollisterStier PCI Pharma Services Grand River Aseptic Manufacturing Catalent Thermo Fisher Scientific Lonza Carbogen Amcis Alcami Delpharm Fareva WuXi Biologics IDT Biologika Emergent CDMO BSP Pharmaceuticals Aenova Samsung Biologics Ajinomoto Bio-Pharma Services Selkirk Pharma INCOG BioPharma Services ten23 health Berkshire Sterile Manufacturing Sponsor: Vetter Pharma International GmbH
Links:
Subscribe to our e-newsletter at www.dcatvci.org
Follow us on Twitter @DCATvci
Support the show
Support the show -
Drug Products: Key Trends & Recent Approvals
What are noteworthy trends in drug delivery and drug-product development in key dosage forms: solid dosage and parenteral drugs? A look at key technology advances and recent new drug approvals. For the text version of this article visit dcatvci.org.
Key topics: (see Chapter Markers in drop down menu in audio player above)
Recent trends: new drug approvalsTechnology advancesEnable Injections’ on-body subcutaneous drug-delivery systemLilly’s and Triastek’s pact for 3-D printing for oral drug deliveryMultifunctional wireless robots in drug deliveryAdvances in implantable devices for drug delivery
Sponsor: Vetter Pharma International GmbH
Links:
Subscribe to our e-newsletter at www.dcatvci.org
Follow us on Twitter @DCATvci
Support the show
Support the show